Evidence map›Paper›PMID 27631432›Full record

ArticlePlant molecular biology2016

The germin-like protein OsGLP2-1 enhances resistance to fungal blast and bacterial blight in rice.

Qing Liu, Jianyuan Yang, Shijuan Yan, Shaohong Zhang, Junliang Zhao, Wenjuan Wang, Tifeng Yang, Xiaofei Wang, Xingxue Mao, Jingfang Dong and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Plant molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Infection by3 Biotech · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Recent Progress in Rice Broad-Spectrum Disease Resistance.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Qing LiuGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Jianyuan YangGuangdong Key Laboratory of New Technology in Plant protection, Plant Protection Research Institute, Guangdong Academy of Agricultural Sciences, Wushan, Tianhe District, Guangzhou, 510640, China.
Shijuan YanAgro-biological Gene Research Center, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Shaohong ZhangGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Junliang ZhaoGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Wenjuan WangGuangdong Key Laboratory of New Technology in Plant protection, Plant Protection Research Institute, Guangdong Academy of Agricultural Sciences, Wushan, Tianhe District, Guangzhou, 510640, China.
Tifeng YangGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Xiaofei WangGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Xingxue MaoGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Jingfang DongGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China.
Xiaoyuan ZhuGuangdong Key Laboratory of New Technology in Plant protection, Plant Protection Research Institute, Guangdong Academy of Agricultural Sciences, Wushan, Tianhe District, Guangzhou, 510640, China. gzzhuxy@tom.com.
Bin LiuGuangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou, 510640, China. lbgz1009@163.com.
Guangdong Academy of Agricultural Sciences · CNRice Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key messageThis is the first report that GLP gene (OsGLP2-1) is involved in panicle blast and bacterial blight resistance in rice. In addition to its resistance to blast and bacterial blight, OsGLP2-1 has also been reported to co-localize with a QTLs for sheath blight resistance in rice. These suggest that the disease resistance provided by OsGLP2-1 is quantitative and broad spectrum. Its good resistance to these major diseases in rice makes it to be a promising target in rice breeding. Rice (Oryza sativa) blast caused by Magnaporthe oryzae and bacterial blight caused by Xanthomonas oryzae pv. oryzae are the two most destructive rice diseases worldwide. Germin-like protein (GLP) gene family is one of the important defense gene families which have been reported to be involved in disease resistance in plants. Although GLP proteins have been demonstrated to positively regulate leaf blast resistance in rice, their involvement in resistance to panicle blast and bacterial blight, has not been reported. In this study, we reported that one of the rice GLP genes, OsGLP2-1, was significantly induced by blast fungus. Overexpression of OsGLP2-1 quantitatively enhanced resistance to leaf blast, panicle blast and bacterial blight. The temporal and spatial expression analysis revealed that OsGLP2-1is highly expressed in leaves and panicles and sub-localized in the cell wall. Compared with empty vector transformed (control) plants, the OsGLP2-1 overexpressing plants exhibited higher levels of H

Indexed as

CyclopentanesDisease ResistanceGene Expression Regulation, PlantGlycoproteinsHydrogen PeroxideMagnaportheOryzaOxylipinsPlant DiseasesPlant Growth RegulatorsPlant ProteinsPlants, Genetically ModifiedXanthomonasCyclopentanesgerminGlycoproteinsHydrogen Peroxidejasmonic acidOxylipinsPlant Growth RegulatorsPlant ProteinsBacterial blightH2O2Jasmonic acidOryza sativaOsGLP2-1Rice blast

Identifiers

PMID27631432
OpenAlexW2519537815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.